Critical appraisal of commonly used treatment for genital warts

R Maw - International journal of STD & AIDS, 2004 - journals.sagepub.com
Genital warts are one of the most commonly reported sexually transmitted diseases
worldwide. A variety of treatment options are available but few have been assessed in large …

Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK

RE Brown, JG Breugelmans… - … medical research and …, 2006 - Taylor & Francis
ABSTRACT Objective: Infection with human Papillomavirus (HPV) is a necessary cause of
cervical cancer (CC) and genital warts (GW). HPV vaccination studies have shown excellent …

[HTML][HTML] Hospital resource utilisation from HPV-related diseases in England: a real-world cost analysis

G Fabiano, A Marcellusi, FS Mennini… - The European Journal of …, 2023 - Springer
Background and objective HPV (human papillomavirus) is the virus most often responsible
for sexually transmitted infections. The burden of HPV-related diseases on hospital …

The economic impact of HPV vaccines: not just cervical cancer

ER Myers - American Journal of Obstetrics & Gynecology, 2008 - ajog.org
Cervical cancer is the leading cause of cancer death among women worldwide. Although
regular screening dramatically reduces the incidence and death from cervical cancer …

Lifetime medical costs of genital herpes in the United States: estimates from insurance claims

ST Eppink, S Kumar, K Miele… - Sexually transmitted …, 2021 - journals.lww.com
Background The purpose of this study was to estimate the lifetime direct medical costs per
incident case of genital herpes in the United States. Methods We used medical claims data …

Clinical and economic burden of HPV-related cancers in the US veteran population

K Saxena, RS Dawson, A Cyhaniuk… - Journal of Medical …, 2022 - Taylor & Francis
Background Human papillomavirus (HPV) is one of the most common sexually transmitted
infection in the United States and can lead to cervical, vulvovaginal, anal, penile, and …

[HTML][HTML] The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches

TD Szucs, K Berger, DN Fisman, S Harbarth - BMC infectious diseases, 2001 - Springer
Background Only limited data exist on the costs of genital herpes (GH) in the USA. We
estimated the economic burden of GH in the USA using two different costing approaches …

Mean medical costs associated with vaginal and vulvar cancers for commercially insured patients in the United States and Texas

S Fu, DR Lairson, W Chan, CF Wu, L Ramondetta - Gynecologic oncology, 2018 - Elsevier
Objective To estimate the average medical costs for vaginal and vulvar cancers in a
commercially insured population in the US and Texas. Methods 2011–2014 US MarketScan …

Structural differences among cost–effectiveness models of human papillomavirus vaccines

RP Insinga, EJ Dasbach, EH Elbasha - Expert Review of Vaccines, 2008 - Taylor & Francis
In this article we compare previously published cost–effectiveness studies of human
papillomavirus (HPV) vaccines along a defined subset of key model structural assumptions …

[HTML][HTML] Recurrent genital herpes treatments and their impact on quality of life

MH Brentjens, KA Yeung-Yue, PC Lee, SK Tyring - Pharmacoeconomics, 2003 - Springer
Herpes genitalis is one of the most common viral sexually transmitted diseases in the world,
with an estimated seroprevalence in the US of greater than 20%. Two viruses of the same …